277 related articles for article (PubMed ID: 37055898)
1. Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders.
Sharma R; Kumarasamy M; Parihar VK; Ravichandiran V; Kumar N
CNS Neurol Disord Drug Targets; 2024; 23(5):638-655. PubMed ID: 37055898
[TBL] [Abstract][Full Text] [Related]
2. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
Naoi M; Riederer P; Maruyama W
J Neural Transm (Vienna); 2016 Feb; 123(2):91-106. PubMed ID: 25604428
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase inactivation: from pathophysiology to therapeutics.
Bortolato M; Chen K; Shih JC
Adv Drug Deliv Rev; 2008; 60(13-14):1527-33. PubMed ID: 18652859
[TBL] [Abstract][Full Text] [Related]
4. Perseveration in a spatial-discrimination serial reversal learning task is differentially affected by MAO-A and MAO-B inhibition and associated with reduced anxiety and peripheral serotonin levels.
Zhukovsky P; Alsiö J; Jupp B; Xia J; Giuliano C; Jenner L; Griffiths J; Riley E; Ali S; Roberts AC; Robbins TW; Dalley JW
Psychopharmacology (Berl); 2017 May; 234(9-10):1557-1571. PubMed ID: 28251298
[TBL] [Abstract][Full Text] [Related]
5. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.
Bortolato M; Shih JC
Int Rev Neurobiol; 2011; 100():13-42. PubMed ID: 21971001
[TBL] [Abstract][Full Text] [Related]
6. Forebrain-specific expression of monoamine oxidase A reduces neurotransmitter levels, restores the brain structure, and rescues aggressive behavior in monoamine oxidase A-deficient mice.
Chen K; Cases O; Rebrin I; Wu W; Gallaher TK; Seif I; Shih JC
J Biol Chem; 2007 Jan; 282(1):115-23. PubMed ID: 17090537
[TBL] [Abstract][Full Text] [Related]
7. Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice.
Bortolato M; Godar SC; Davarian S; Chen K; Shih JC
Neuropsychopharmacology; 2009 Dec; 34(13):2746-57. PubMed ID: 19710633
[TBL] [Abstract][Full Text] [Related]
8. Regulation of monoamine oxidase A by the SRY gene on the Y chromosome.
Wu JB; Chen K; Li Y; Lau YF; Shih JC
FASEB J; 2009 Nov; 23(11):4029-38. PubMed ID: 19661285
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic role for a novel glucocorticoid-KLF11 (TIEG2) protein pathway in stress-induced monoamine oxidase A expression.
Grunewald M; Johnson S; Lu D; Wang Z; Lomberk G; Albert PR; Stockmeier CA; Meyer JH; Urrutia R; Miczek KA; Austin MC; Wang J; Paul IA; Woolverton WL; Seo S; Sittman DB; Ou XM
J Biol Chem; 2012 Jul; 287(29):24195-206. PubMed ID: 22628545
[TBL] [Abstract][Full Text] [Related]
10. Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation.
Ugun-Klusek A; Theodosi TS; Fitzgerald JC; Burté F; Ufer C; Boocock DJ; Yu-Wai-Man P; Bedford L; Billett EE
Redox Biol; 2019 Jan; 20():167-181. PubMed ID: 30336354
[TBL] [Abstract][Full Text] [Related]
11. Drugs related to monoamine oxidase activity.
Fišar Z
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():112-24. PubMed ID: 26944656
[TBL] [Abstract][Full Text] [Related]
12. Role of monoamine oxidase-B in medroxyprogesterone acetate (17-acetoxy-6 alpha-methyl-4-pregnene-3, 20-dione) induced changes in brain dopamine levels of rats.
Tandon P; Gupta ML; Barthwal JP; Gupta TK; Parmar SS; Bhargava KP
Steroids; 1983 Sep; 42(3):231-9. PubMed ID: 6231746
[TBL] [Abstract][Full Text] [Related]
13. Smoking related diseases: the central role of monoamine oxidase.
Rendu F; Peoc'h K; Berlin I; Thomas D; Launay JM
Int J Environ Res Public Health; 2011 Jan; 8(1):136-47. PubMed ID: 21318020
[TBL] [Abstract][Full Text] [Related]
14. Brain injury and inflammation genes common to a number of neurological diseases and the genes involved in the genesis of GABAnergic neurons are altered in monoamine oxidase B knockout mice.
Chen K; Palagashvili T; Hsu W; Chen Y; Tabakoff B; Hong F; Shih AT; Shih JC
Brain Res; 2022 Jan; 1774():147724. PubMed ID: 34780749
[TBL] [Abstract][Full Text] [Related]
15. A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior.
Chen K; Holschneider DP; Wu W; Rebrin I; Shih JC
J Biol Chem; 2004 Sep; 279(38):39645-52. PubMed ID: 15272015
[TBL] [Abstract][Full Text] [Related]
16. Chronic postnatal monoamine oxidase inhibition affects affiliative behavior in rat pupso.
Blazevic S; Merkler M; Persic D; Hranilovic D
Pharmacol Biochem Behav; 2017 Feb; 153():60-68. PubMed ID: 27989747
[TBL] [Abstract][Full Text] [Related]
17. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish.
Sallinen V; Sundvik M; Reenilä I; Peitsaro N; Khrustalyov D; Anichtchik O; Toleikyte G; Kaslin J; Panula P
J Neurochem; 2009 Apr; 109(2):403-15. PubMed ID: 19222706
[TBL] [Abstract][Full Text] [Related]
18. Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine.
Steuer AE; Boxler MI; Stock L; Kraemer T
Toxicol Lett; 2016 Jan; 243():48-55. PubMed ID: 26721607
[TBL] [Abstract][Full Text] [Related]
19. Abnormal brain development of monoamine oxidase mutant zebrafish and impaired social interaction of heterozygous fish.
Baronio D; Chen YC; Panula P
Dis Model Mech; 2022 Mar; 15(3):. PubMed ID: 34881779
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
Griebel G; Curet O; Perrault G; Sanger DJ
Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
